Notably, CLDN6 overexpression significantly reduced cell viability (Supplementary Fig. 1B) and clonogenicity (Supplementary Fig. 1C) while induced G1/S phase arrest across different BC cell lines (Supplementary Fig. 1D). This evidence concerns the gene CLDN6 and breast cancer.